The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic…

Overview of attention for article published in Journal of the American Academy of Dermatology, April 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 41 news outlets
blogs: 2 blogs
policy: 1 policy source

twitter: 7 X users
patent: 17 patents
guideline: 2 clinical guideline sources

Readers on

mendeley: 155 Mendeley

So far, Altmetric has seen 143 news stories from 41 outlets.

European Commission approval of ICOTYDE™▼(icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

BioSpace, 22 Sep 2026

Johnson

ICOTYDE (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once-daily pill for plaque psoriasis

Medindia, 30 Mar 2026

PR Newswire SPRING HOUSE, Pa., March 28, 2026 Johnson

ICOTYDE™ (icotrokinra) one-year results demonstrate lasting skin clearance and favourable safety profile in once-daily tablet for plaque psoriasis

PharmiWeb, 30 Mar 2026

- High rates of complete skin clearance achieved at Week 24 and Week 52 in ICONIC-ADVANCE 1 and 2 studies.

News story from Finanz Nachrichten on Saturday 28 March 2026

Finanz Nachrichten, 28 Mar 2026

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 139 additional news stories.